Antibody detection and accurate diagnosis of tropical diseases is essential to help prevent the 21 spread of disease. However, most detection methods lack cost-effectiveness and field-portability, 22
To address this problem, transparent 3D printed sample chambers with a total volume of 700 24 microliters and an oblate spheroid shape were fabricated to measure green light scattering of gold 25 nanoparticles using an optical caustic focus to detect antibodies. Scattering signals from 90 degree 26 scattering of 20, 40, 50, 60, 80, 100, and 200 nm gold nanoparticles using a green laser and standard 27 quartz cuvette were compared to the scattering signals from a green LED light source with an 28 oblate spheroid sample chamber and to Mie theory by fitting the data to a logistic curve. The 29 change in signal from 60 nm to 120 nm decreased in the order of Mie Theory > Optical Caustic 30 scattering > standard laser 90 degree scattering. These results suggested that conjugating 60 nm 31 gold nanoparticles with Dengue Protein E and using an optical caustic system to detect plasmonic 32 light scattering would result in a sensitive test for detecting human antibodies against Dengue 33
Protein E in serum. To explore this possibility, we studied the light scattering response of protein 34 E conjugated gold nanoparticles exposed to different concentrations of anti-protein E antibody, 35
and posteriorly via a feasibility study consisting of 10 human serum samples using a modified dot 36 blot protocol and a handheld optical caustic-based sensor device. The overall agreement between 37 the benchtop light scattering and dot blot results and the handheld optical caustic sensor suggest 38
that the new sensor concept shows promise to detect gold nanoparticle aggregation caused by the 39 presence of the antibody using a homogeneous assay. Further testing and protocol optimization is 40 needed in order to draw conclusions on the positive predictive and negative predictive values for 41 this new testing system. The development of a rapid and accurate means for identifying the cause of a systemic infection 47 has been a subject of intense interest due to the need for proper course of treatment in order to 48 improve patient outcomes. Also, there is a growing need for accurate diagnoses due to the toll in 49 human and economic terms caused by endemic diseases transmitted by mosquitoes in tropical 50 regions. Of particular focus in developing countries in the tropical region, is the ability to ascertain 51 whether a patient has contracted Dengue Fever and specifically which serotype (DEN-1, 2, 3, 4) 52
is the probable cause of the illness. While symptomatic diagnostics play an important role in all 53 febrile disease management, some patients are asymptomatic or have mild symptoms, and 54 diagnosis of these patients can be critical because Dengue Fever serotypes are believed to be 55 directly linked to severe courses of infection such as Dengue Shock syndrome (DSS) and Dengue 56
Hemorrhoragic Fever (DHF), making early serotype identification a potentially valuable tool. 57
Moreover, confirmation of whether the patient has had a prior serotype infection, which has also 58 been linked to DSS and DHF, can also help to determine the course of treatment and further steps 59 to prevent an outbreak of Dengue [8] [9] [10] [11] . 60
In order to meet the need for a rapid diagnostic that can be implemented in the field and closely 61 based on patient exposure and/or immune response at an early stage of patient reported symptoms, 62 a hybrid approach that combines gold nanoparticle conjugates (similar to what is used in low-cost 63 paper diagnostics based on lateral flow immunoassay technology) with a high level of sensitivity 64 in conjunction with a portable sensor for detecting a positive response at low antigen levels is the 65 subject of this feasibility study. In order to establish a relatively low cost diagnostic tool, the 66 hybrid technology described in this paper builds upon the employment of an optical caustic light 67 scattering technology that employs no lenses and does not need filters [1] . Moreover, the use of 68 battery powered LEDs and the deployment of a smartphone to analyze the scattered light are also helpful in reducing cost as well as in improving access to the device for low and middle income 70
countries. 71
To commence a process of verifying the capabilities of the new hybrid technology platform in a 72 simulated low resource setting, our approach was to first determine if an existing Dengue 73 molecular reagent used for gold nanoparticle conjugation in paper assays could detect Dengue 74 antibodies with human patient samples by employing this new hybrid technology platform. For 75 the first part of this study, we analyzed the 90 degree light scattering response of conjugated gold 76 nanoparticles to different concentrations of anti-Protein E antibody to determine key parameters 77 such as: (1) size of gold nanoparticle that should be used; and (2) stability of the gold nanoparticle 78 conjugates when subjected to transportation and varying temperature conditions. For the second 79 part of the study, a direct approach with clinically relevant samples was used since it is a faster 80 way to determine other important parameters such as: (1) whether very small amounts of human 81 serum samples can yield reasonable signals; (2) determine the need for additional dilution or 82 blocking steps when working with human serum; and (3) whether room or body temperature and 83 incubation time generate differences in measurement. Thus, the overall objective of this feasibility 84 study is solely to gain experience in practical aspects of developing a rapid and hybrid quantitative 85 assay for determining Dengue infection by monitoring patient antibody response while simulating 86 a low resource setting in order to expand testing in a variety of locales and with a wider variation 87 in infrastructure than is normally the case in high income country clinics and hospitals. 88 89
Materials and Methods 90

Gold Nanoparticle Light Scattering Calibration 91
For calibration purposes, unconjugated gold nanoparticles of 20, 40, 50, 60, 80, 100, and 200 nm 92 (Ted Pella Inc., Reading, CA) were diluted 1:10 in distilled deionized water and analyzed for light 93 scattering and extinction using three separate detection methods. Each gold particle size sample 94 contained the same overall molar concentration of gold. 95
Gold Nanoparticle Conjugation 96
In a 1.5 ml Eppendorf tube, an aliquot of 1 ml containing 2.6 x 10 10 particles/ml of 60 nm gold 97 colloids (Ted Pella Inc, Redding, CA) was combined with 100 microliters of freshly prepared pH 98 = 8.5 borate buffer prior to the addition of 50 microliters of 0.85 mg/ml Protein E Dengue 99
Envelope-2 32 kDA (MCR-054, Reagent Proteins, Pfenex Inc., San Diego, CA). A frozen cold 100 pack was placed on the tube and the mixture was gently rocked using an orbital table for 30 101 minutes. This was followed by the addition of 2.5 microliters of 10% Tween 20 and rocking on 102 the orbital table for 5 more minutes. 103
One or three centrifugation steps were then conducted in order to reduce the concentration of 104
unbound Protein E form the suspension. A Beckman Coulter Microfuge 18 (Beckman Coulter, 105 Brea, CA) was placed in a 4˚C environmental room in order to minimize aggregation of gold 106 nanoparticles and ensure resuspension after centrifugation. The first centrifugation was for 30 107 minutes at 3500g. Immediately after centrifugation, as much of the supernatant as possible was 108 carefully removed from the pellet using a 200 microliter micropipette, while not disturbing the 109 pellet. Once this was accomplished, 1 ml of pH = 8.5 borate buffer was added to re-suspend the 110
pellet. An aliquot of 2.5 microliters of 10% Tween 20 was then added to the suspension and the 111 mixture was gently rocked for 5 minutes. Afterwards, the suspension was centrifuged again for 112 15 minutes at 3500g. The same procedure was used following the second centrifugation as 113 described for the first centrifugation step. For the 3 rd centrifugation, the time was shortened to 10 minutes. After the third and final centrifugation, the pellet was re-suspended in 0.5 ml of a 0.2 115 mg/ml solution of Bovine Serum Albumin (BSA) in DI water to block the remaining unreacted 116 sites on the gold nanoparticles. The particles were then incubated on the orbital table for an 117 additional 5 minutes. This was followed by the addition of 0.5 ml of DI water and 0.5% sodium 118 azide. 119
Detection of anti-Protein E antibody in vitro 120
To 100 µl of conjugated gold nanoparticles, 900 µl of PBS were added. Posteriorly, 10 µl of 121 different concentrations of anti-Protein E antibody were added prior to measuring 90-degree light 122 scattering using the oval plastic chamber and the handheld optical caustic sensor which used a 123
Nokia 920 smartphone and Lumia software for imaging. Pictures of the oval chamber were taking 124 using different times of exposure (0.1 sec or 1 sec) and by reducing overall brightness to the lowest 125 level in the Lumia camera app. The images were analyzed measuring the raw intensity using 126 ImageJ using the green or red channel, depending upon the level of saturation of the green channel, 127 and by focusing in the zone of the sample chamber where scattering by the gold nanoparticles 128 provides pixels with brightness above the typical PBS solution pixel values of 0-5 (out of a 129 maximum range of 255). 130
Dot Blot using conjugated Gold nanoparticles 131
Standard dot blot paper (Bio Rad Laboratories, Hercules, CA) was cut into rectangular or 132 hexagonal shapes in order to fit into 12 well Corning Costar Tissue Culture Plates (Ted Pella Inc., 133
Reading, CA). After punching a hole in the center of the paper with a sterile pin, 3 microliters of 134 1:100 PBS diluted human serum was placed over the area around the pin hole and allowed to dry 135 for 5 minutes at 37 ˚C. Then, the paper was cooled to 4 ˚C and allowed to incubate for 15 minutes. 136 to the chamber and mixed for 15 minutes at room temperature. After incubating in the blocking 138 solution for 30 minutes at 37 C, an aliquot of 500 microliters of a 1:10 diluted suspension of 60 139
nm Protein E conjugated gold nanoparticle was added to the paper. Incubation with the gold 140 nanoparticle conjugate was conducted for 1 hour at 37 ˚C. After the final incubation, the paper 141 was rinsed 3 times in PBS -Tween 20 buffer and allowed to dry. 142
Testing of Human Serum Samples 143
All human serum samples were obtained voluntarily from Hemolab S.A. and the Lab of 144
Arbovirology of the Universidad Autonoma de Yucatán collected for previous studies. Two 6 ml 145 bottles of conjugated gold nanoparticle reagent GNP-60-E were created according to the protocol 146 described above except that while one GNP reagent (GNP-60-E-3) was centrifuged 3 times to 147 remove unbound Protein E, a second reagent (GNP-60-E-1) was centrifuged only once. Both 148 reagents were stored for 16 hours at 4 ˚C then transported at room temperature for 19 hours, until 149 refrigerated at 4 ˚C at the Universidad Autónoma de Yucatán (UADY). Both GNP-60-E reagents 150 arrived un-aggregated at UADY based on both Nanodrop spectrometer (Bio Rad Laboratory, 151
Hercules, CA) visible spectra taken at the Universidad Autónoma del Yucatán (UADY) before 152 using the reagents and by visual observation of the gold nanoparticle suspension. 153
For each test, in a 1.5 ml Eppendorf tube, 900 µl of PBS were combined with 100 µl of the gold 154 nanoparticle conjugate followed by the addition of 5 or 10 microliters of the human serum samples 155 or a negative control of PBS. For the testing at 37 ˚C, GNP-60-E-3 was used and 10 microliters of 156 undiluted human serum was added. Incubation was performed for 30 minutes at 37 ˚C without 157 agitation. Afterwards, each test sample was placed in an oblate spheroid chamber and capped, 158 followed by imaging with the smartphone sensor. For the first trial at 22 ˚C, GNP-60-E-3 was used 159 and 5 microliters of undiluted human serum was added. Incubation was performed for 15 minutes at 22 ˚C without agitation. Afterwards, each test sample was placed in an oblate spheroid chamber 161 and capped, followed by imaging. For the second trial at 22 ˚C, GNP-60-E-1 was used and 2 162 microliters of 1:10 diluted human serum was added. Incubation was performed for 15 minutes at 163 22 ˚C without agitation. Afterwards, each test sample was placed in an oblate spheroid chamber 164 and capped, followed by imaging. 165
Light Scattering Measurement Systems 166
For 90-degree laser light benchtop scattering measurements, an Ocean Optics Fiber Optic 167
Spectrometer (Ocean Optics, Dunedin, FL) was used with a USB4000 spectrometer and 168
SpectraSuite Software for control and data acquisition. A quartz cuvette of 1 cm path length with 169 all four windows clear for measurement enables 90-degree placement of an InPhotonics 532 nm 170 laser, with an Ocean Optics controller from the fiber optic collector, to measure counts of scattered 171 light. Readings of 1 second integration time with 5 spectra averaging was used. 172
3D Printed Oblate Spheroid Chamber 173
Autodesk Fusion 360 software was used to generate the 3D oblate spheroid sample chamber used 174 in the handheld optical caustic sensor. In order to place the sample chamber in the LED 175 illumination chamber and easily remove it after imaging, a solid rectangular peg was added to the 176 center of the base. The opening of the sample chamber was sized and designed with a small ridge 177 in order to accommodate lids cut from 200 microliter PCR tubes. Fabrication of the sample 178 chambers were done in batches of 12 by transmitting the drawing to a 3D printing company 179 (iMaterialise, Leuven, Belgium). 3D printing is conducted using stereolithography with a 180 transparent resin and the finished product is between water clear and translucent, in terms of 181 visibility to the naked eye. was acquired using between 0.1 -30 seconds integration time. Since a lower intensity of LED light was used than with the smartphone system, data for 20, 40, 50, 60, 80, 100, and 200 nm was 207 collected for the green channel of the sensor. The most accurate data to compare scattering using 208 the digital color sensor in this system was the highest integration time of 30 seconds, which was 209 then used to compare with the smartphone light scattering results. 210 211
Results and Discussion 212
Before conjugation of Protein E to gold nanoparticles, the choice of gold nanoparticle size was 213 deemed to be a key variable that needed to be determined. Based on the well understood properties 214 of gold nanoparticles to light scattering via plasmon resonance [6] near the maximum for spheres 215 of 520-540 nm, a calibration was conducted with a laser light scattering fiber optic spectrometer, 216 the optical caustic sensor, and calculations based on Mie Theory [6]. Figure 1 illustrates two key 217 points. First, that the laser light scattering system which is based on 90 degree scattering is 218 sensitive to small changes in particles size at a narrow range of between 30-70 nm diameter 219 particles. Mie Theory calculations illustrate that the total scattering for gold nanoparticles 220 increases more gradually with size, since this calculation takes into account all angles of scattering. 221
The Optical Caustic sample chamber is seen in Figure 1 to fall between the two groups of data, 222 using both a camera and a digital color sensor to collect data. It was also found that the red channel 223 of the smartphone RGB image was most useful based on the LED intensity and shutter speed 224 setting since smartphone sensor saturation "bleeds" signal to the red and blue channels when there 225 is an excess of green in the image. The digital color sensor corroborates that interpretation, as 226 shown in Figure 1 . The overall interpretation of the calibration data is that using 60 nm gold particles is very practical 236
for the intended application. The reason for this is that there is a dramatic (approximately 340%) 237 increase in signal predicted when two 60 nm gold particles aggregate upon antibody-antigen 238 binding, basically the change in relative signal from 60 nm to 120 nm gold particle size. 239
After establishing that 60 nm gold particles would be a useful size, it is also important to note that 240 conjugated gold nanoparticles are sensitive optically to any surface change, including binding of 241 antibodies or antigens to their surfaces and the additional binding of proteins to their surfaces or 242 aggregation of gold nanoparticles. To establish the response of the system in terms of 90-degree 243 light scattering near the plasmon resonant peak, different amounts of anti-Protein E antibody were 244 added to a diluted solution of conjugated gold nanoparticles. The first parameter to determine was 245 the zone for no scattering in the chamber, and in this case PBS without gold nanoparticles was 246 used. Images taken with 1 sec of exposure and analyzed using the red channel since the green 247 channel was already saturated with green light ( Figure 2B) shows that when using PBS, the amount 248 of light detected from the center of the sample chamber is very low since no scattering nor 249 reflection is expected in this zone of the sample chamber. Other images using different exposure 250 times with the green channel did not provide a sufficiently good baseline dark zone, so the most appropriate exposure time for imaging for the handheld optical caustic smartphone was determined 252 to be a 1 sec exposure in the center zone of the images' red channel. Next, images were taken for an aqueous suspension of 60 nm gold nanoparticles using the same 262 imaging settings as for PBS. Figure 2C shows that the region given as a dark area when imaging 263 PBS, now contains brightness due to gold nanoparticle light scattering. The integrated difference 264 for these two measurements is on the order of 100x, which clearly provides a high range for 265 detecting small changes in gold nanoparticle scattering. It is important to note that this signal is 266 based on only ~1.8 billion gold nanoparticles in 0.7 ml of suspension, which suggests that detection 267 to a sensitivity of 50 pg/ml of antibody or antigen should be possible since it could represent a 1% 268 difference in nanoparticle scattering signal. 269
Finally, in order to quickly explore the range of signal change possible for a commercially 270
available Protein E antigen with the handheld optical caustic sensor, the light scattering intensity 271 for a gold nanoparticle suspension and gold nanoparticles containing Protein E in the presence of 272 10 µg/ml of anti-Protein E antibody in PBS. Table 1 gives the gray value differences for the 273 controls and the antibody test. The initial challenge lay in interpreting patient results without an extensive study of the antigen 280 protein structure nor its immunogenic properties when presented on gold nanoparticle surfaces. 281
This makes discerning the performance of the tests with respect to patient Dengue status 282 characterization challenging. The challenge is somewhat reduced by using a dot blot test with the 283 same patient samples and gold conjugate reagents as an orthogonal test. Table 2 antigen Protein E used as the reagent conjugated to the gold nanoparticles is a recombinant protein 292 with selectivity towards Dengue Serotype 2 antibodies and is described by the manufacturer as 293 being most sensitive to IgM levels. However, it is known that there can be cross-reactivity to other 294 dengue serotype antibodies as well as from patients who have experienced other arbovirus 295 infections from the group known as flaviviruses such as West Nile, St. Louis Encephalitis, Zika Virus, and Chikungunya [4] . These considerations suggest that there should be some variation in 297 test results, but the variations may be difficult to discern without a more comprehensive series of 298 human serum controls. 299 300 Before commencing patient testing, the 60 nm gold conjugates were inspected and the UV/VIS 308 spectra were recorded for the two batches of particle conjugates (Figure 3 ). Both visual and 309 spectral information verified that the gold conjugates were stable and ready to use at UADY. 310 Table 3 summarizes the expected dot blot score based on the protein E gold conjugate reagent 316 (GNP-60-E-3) used, assuming some level of cross-reactivity with other Dengue serotypes and a 317 50% probability of measuring antibodies reactive to Protein E after 120 days of convalescence. 318
The individual blot samples and the scores of the dot blot are shown in Figure 4 and in Table 3 . Overall, the agreement is very good. However, the two dengue negative patients appear to give 330 positive dot blot results. It is not clear why this is the case, but perhaps a current or prior flavivirus 331 infection is being detected by the gold conjugate reagent. Additionally, the sample with PBS added 332 and no human serum was correctly identified as a negative control in the dot blot experiment. It 333 is also important to note that a dot blot test (not shown) with a monoclonal antibody that reacts 334 with flavivirus group specific antigens (4G2, KPL) was found to be negative. The negative result 335 suggests that epitopes of the protein envelope needed for the monoclonal antibody to bind to the 336 GNP-60-E-3 were blocked due to the immobilization of Protein E to the gold nanoparticles. This 337 is a potentially useful observation for further gold conjugate development, namely if a 338 methodology for Protein E binding to gold based on covalent attachment rather than his-tag is 339
used. 340
A summary of the three sets of tests with human serum samples and an overall score is given in 341 Table 4 while a quantitative comparison of the dot blot is shown in Figure 5 . The overall score 342 given in Table 3 is based on assessing the differences among the three tests using gold 343 nanoparticles made with either 3 or 1 centrifugation step(s) and at different times and temperatures. 344
Based on the results in Table 3 , it appears that the results with GNP-60-E-1 at 22 C for 15 minutes 345 seem to be most closely related to the characterization based on the dengue patient status In Figure 5 , there are two overall features to note. First it appears that the smartphone signal 356 saturates at low "signals" from the dot blot experiments. This seems reasonable given the high 357 signal change described in Figure 1 and 2 for aggregates consisting of 60 nm gold particles. The 358 second feature is that the negative control and patient sample 10 are both low for the dot blot and 359 the optical caustic sensor, but there is disagreement between patient samples 5 and 6 between the 360 two detection methods. This may be due to the higher sensitivity of the optical caustic sensor as 361 compared to the dot blot which used gold nanoparticles at a higher level of dilution. Dot blots are 362 also considered to be lower in sensitivity due to diffusion and orientation effects when binding to Another observation is that patient sample 7 yielded a very weak signal and patient sample 10 is 365 negative based on the dot blot tests, yet the optical caustic sensor data show strong signals. This 366 again may be due to higher sensitivity of the optical caustic system and cross reactivity of the 367 Dengue Serotype 2 recombinant Protein E with other Dengue serotypes. As noted in the results 368 for GNP-60-E-1 at 22 C and 15 minutes seen in Table 4 , it appears that this cross-reactivity may 369 be diminished by using a higher dilution of human serum, lower temperature, and allowing some 370 unbound antigen in the gold nanoparticle conjugation suspension. 371 372
Conclusions 373
A feasibility study of a hybrid gold nanoparticle with an optical caustic sensor system indicates 374 that the technology is sensitive to the detection of serum antibodies against dengue fever. The use 375 of similar size gold nanoparticles (60 nm) to what is often used in paper lateral flow rapid tests is 376 justified based on calibration data and human patient sample testing. The gold nanoparticle 377 conjugates are stable to transportation and temperature fluctuations and appear to be un-aggregated 378 and active after several days of conjugation. Also, all negative controls for the dot blot and optical 379 caustic sensors were correctly measured as negative. 380
Dot blot tests were found to be useful to verify the reactivity of the gold nanoparticle conjugates 381 to patient serum antibodies and may also help identify epitope presentation differences when 382 applying monoclonal antibodies to the dot blot paper directly. It appears that human serum should 383 be diluted and that testing can be done at around 22 ˚C within 15 minutes using the hybrid gold 384 nanoparticle conjugate reagent and optical caustic sensor. A more thorough investigation of well 385 characterized human serum samples is still needed in order to optimize the test conditions and 386 buffer components and generate positive predictive and negative predictive values that reflect the 387 capabilities of the diagnostic platform. 388 389
